Benutzer: Gast  Login
Titel:

Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment Strategy.

Dokumenttyp:
Journal Article
Autor(en):
Hemetsberger, Rayyan; Richardt, Gert; Lahu, Shqipdona; Valina, Christian; Menichelli, Maurizio; Abdelghani, Mohammad; Wöhrle, Jochen; Toelg, Ralph; Witzenbichler, Bernhard; Mankerious, Nader; Liebetrau, Christoph; Bernlochner, Isabell; Hamm, Christian W; Allali, Abdelhakim; Joner, Michael; Fusaro, Massimiliano; Xhepa, Erion; Hapfelmeier, Alexander; Kufner, Sebastian; Sager, Hendrik B; Schüpke, Stefanie; Laugwitz, Karl-Ludwig; Schunkert, Heribert; Neumann, Franz-Josef; Kastrati, Adnan; Cassese, S...     »
Abstract:
BACKGROUND: Whether the access site influences the comparative efficacy and safety of ticagrelor and prasugrel in patients with acute coronary syndrome (ACS) undergoing invasive treatment strategy remains unstudied. METHODS: This post-hoc analysis included ACS patients undergoing invasive treatment via radial or femoral access and randomized to either ticagrelor or prasugrel in the ISAR-REACT 5 trial. The primary efficacy endpoint was the composite of death, myocardial infarction (MI) or stroke,...     »
Zeitschriftentitel:
Cardiovasc Revasc Med
Jahr:
2022
Band / Volume:
41
Seitenangaben Beitrag:
122-128
Volltext / DOI:
doi:10.1016/j.carrev.2021.12.029
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/35045943
Print-ISSN:
1553-8389
TUM Einrichtung:
289; Klinik für Herz- und Kreislauferkrankungen im Erwachsenenalter (Prof. Schunkert); Klinik und Poliklinik für Innere Medizin I, Kardiologie
 BibTeX